Physician profile
Christopher A King
NPI 1629191168
$9,056.12
in general payments reported to CMS, 2019-2025
47 companies · $641 in 2025
The $641 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,848 · 2020: $620 · 2021: $1,260 · 2022: $1,063 · 2023: $953 · 2024: $2,672 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,442 · Travel and Lodging: $474 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,441.62 |
| Travel and Lodging | $474.32 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,599.88 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $1,155.01 | 2021-2024 | Auryon Laser System 100-120 Vac, Alphavac |
| Novartis Pharmaceuticals Corporation | $1,017.92 | 2019-2025 | |
| Medtronic, INC. | $390.42 | 2019-2025 | Abre, Hawkone, Symplicity G3 |
| Amgen INC. | $368.27 | 2019-2025 | Repatha, Repatha |
| Silk Road Medical, INC. | $350.00 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Janssen Pharmaceuticals, INC | $341.75 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $276.43 | 2019-2024 | Avvigo Guidance System |
| Pfizer INC. | $276.04 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $272.54 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.17 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $258.44 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $202.39 | 2023-2025 | Impella |
| Impulse Dynamics (USA) INC. | $200.28 | 2022 | |
| Abbott Laboratories | $182.33 | 2020-2025 | Navitor, Esprit, Cardiomems |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.